LINC01767: A Potential Drug Target and Biomarker (G105378744)

Target Name: LINC01767

NCBI ID: G105378744

LINC01767

Other Name(s): CRLM1 | long intergenic non-protein coding RNA 1767 | Long intergenic non-protein coding RNA 1767

LINC01767: A Potential Drug Target and Biomarker

LINC01767 (CRLM1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the CRL family of proteins, which are known for their role in cell signaling. LINC01767 has been shown to play a role in a variety of physiological processes, including cell survival, proliferation, and migration.

One of the most promising aspects of LINC01767 is its potential as a drug target. LINC01767 has been shown to interact with a variety of different signaling pathways, including the NF-kappa pathway. This pathway is involved in a wide range of physiological processes, including cell growth, differentiation, and survival.

LINC01767 has also been shown to interact with the PDGF pathway. This pathway is involved in cell growth, angiogenesis, and Qingfeng signaling. LINC01767 has also been shown to play a role in the regulation of PDGF signaling, which suggests that it may be a useful target for the treatment of diseases that are characterized by abnormal PDGF signaling.

In addition to its potential role in cell signaling, LINC01767 is also of interest as a potential biomarker. The NF-kappa pathway is a well-established biomarker for a wide range of diseases, including cancer. LINC01767 has been shown to be expressed in a variety of cancer types, including breast, lung, and colorectal cancer. This suggests that it may be a useful biomarker for the detection and treatment of these diseases.

In conclusion, LINC01767 is a protein that has the potential to be a drug target or biomarker. Its interaction with the NF-kappa and PDGF pathways suggests that it may be involved in a wide range of physiological processes, including cell survival, proliferation, and migration. Further research is needed to fully understand the role of LINC01767 in these processes and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1767

The "LINC01767 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01767 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets